Identification of ribosomal protein eL21 as a novel externalized protein and a potential target in triple negative breast cancer
Lucie Arnould, Nina Radosevic‐Robin, Laura Duranton, Jérémy Néri, Frederique Madeleine Penault-Llorca, Jean‐Jacques Diaz, Marie Alexandra Albaret, Frédéric Catez
This study identifies eL21 as an externalized ribosomal protein in triple negative breast cancer cells and shows anti-eL21 antibodies induce anti-proliferative effects.
Cancer Gene Therapy · Apr 1, 2026Peer-reviewedCancer Biology